Condition: Bariatric Surgery Candidate · Bile Acid, Elevated Serum · Glucose Metabolism Disorders · Sponsor: Hvidovre University Hospital
Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).
This description comes directly from the study's public registry record.
Marie-Louise Dichman · +4526710371 · marie-louise.dichman@regionh.dk
Carsten Dirksen · carsten.dirksen@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Medicine, Copenhagen University Hospital - Amager and Hvidovre | Hvidovre, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06925997